In the recent publication, Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy, researchers examined treatment modalities to aid the development of PARP inhibitors. These compounds target tumors deficient in the Homologous Recombination...
This presentation on imaging of benign fibromatoses was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Wolfson's presentation recording and slides below. Presentation Recording: Presentation Slides:
Changes in cancer care are driving a demand for improved outcomes at greater efficiency and reduced costs. In this presentation, Dr. Julya Zuenkova describes a value-based approach in radiotherapy to use X-rays for operational efficacy. Learn how these treatments...
This presentation on the Multicenter Patterns of Care Study was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Micke's presentation recording and slides below. Presentation Recording: Presentation Slides:
In the study, Differential Effects of Radiation Fractionation Regimens on Glioblastoma, researchers compared radiation regimens for glioblastomas, and their radiotoxicity and neurocognitive effects. SARRP was used for in vivo and in vitro irradiation in the study. See...
We are thrilled to announce that MuriSuite, a brand new control system for all SARRP devices, will be released this year. Hear more in this video from our CEO, Adrian Treverton and our resident SARRP expert, Wilfried Goetz. https://vimeo.com/710478777
Вебинар ведет профессор Огава (Япония). Вы узнаете о современных эффективных способах лечения келлоидных рубцов, новейших схемах лучевой терапии и реабилитации после лечения. Рей Огава - профессор и заведующий кафедрой пластической и эстетической хирургии больницы...
This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. Dr. Seegenschmiedt's presentation was part of the second session, Radiotherapy for for Hyperproliferative Disorders. See his presentation and slide's below. Presentation...
Each of our systems have unique energy ranges, applicators, and treatment capabilities. Learn which of our radiotherapy systems is right for you and your patients by watching the video below. Our Chief Science Officer, Amanda Tulk, outlines the key differences of each...
Contact Us